Drug Shortage Report for TARO-VALSARTAN
Report ID | 173675 |
Drug Identification Number | 02363119 |
Brand name | TARO-VALSARTAN |
Common or Proper name | VALSARTAN |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | VALSARTAN |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-19 |
Estimated end date | 2023-04-07 |
Actual end date | 2023-04-07 |
Shortage status | Resolved |
Updated date | 2023-04-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2023-04-10 | English | Compare |
v22 | 2023-04-10 | French | Compare |